Lumida
/PRLD
⌘K
Prelude Therapeutics Inc

Prelude Therapeutics Inc

PRLD
$4.59USD-1.71%-0.08 today

MARKET CAP

366.3M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$1
$7
STATEMENT·Income statement
USD · GAAP
METRICFY 2024FY 2025TREND
Sales, Adj.$7.0M$12.1M
YoY %+73.4%
P / Sales13.8x18.4x
EV / Sales18.3x21.5x
Gross Profit, Adj.$7.0M$12.1M
YoY %+73.4%
Margin %100.0%100.0%
EV / Gross Profit18.3x21.5x
EBITDA, Adj.$-137.9M$-102.9M
YoY %-5.2%+25.4%
Margin %-1970.6%-847.2%
EV / EBITDA-0.9x-2.5x
EBIT$-139.7M$-104.6M
YoY %-5.6%+25.2%
Margin %-1995.9%-861.3%
EV / EBIT-0.9x-2.5x
Net Income$-127.2M$-99.5M
YoY %-4.4%+21.8%
Net Margin-1816.8%-819.6%
EPS (GAAP)-$1.68-$1.29
YoY %+16.8%+23.2%